|Articles|July 11, 2012

Drug Cost Control in Oncology

Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Depressed woman | Image Credit: panitan - stock.adobe.com

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

ByBrooke McCormick

January 31st 2026

Trulicity | Image credit: omar - stock.adobe.com

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

ByJulia Bonavitacola

January 28th 2026

The AAP’s 2026 immunization schedule preserves broader vaccine protections as the CDC narrows its federal recommendations. | Image credit: @Katherine Welles - stock.adobe.com .jpeg

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

BySabrina McCrear

January 27th 2026

Child receiving vaccine | Image credit: Drazen - stock.adobe.com

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

ByBrooke McCormick

January 27th 2026

Minnesota clinicians say ICE enforcement near hospitals and clinics is discouraging patients from seeking critical medical care. | Image Credit: @TadaImages-Adobestock.jpeg

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

BySabrina McCrear

January 27th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Drug Cost Control in Oncology

Newsletter

Related Content

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

Virtual Reality Intervention Increased Empathy for Patients With MG

Strong Patient–Doctor Communication Improves Glaucoma Care: Ariana Levin, MD

Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

AI-Supported Mammography Caught More Cancers During Screening